Hu, H., Gao, S., Liu, J., Wang, W., Chang, K., Yin, Y., Liu, X., Meng, Q., Shi, W., Lv, Y. (2026). Integrated metabolomics and network pharmacology reveals that icariin antagonizes malignant phenotypes in triple-negative breast cancer via AKT1/SRC/NFKB1-mediated PI3K‒AKT pathway inhibition. Scientific Reports. https://doi.org/10.1038/s41598-026-63178-8